HerClarityhealth
HomeDiagnosisWhat bloodwork tells you — and what it doesn’t.
Diagnosis · 7 min

What bloodwork tells you — and what it doesn’t.

Why a normal CBC + CMP can sit on top of a textbook perimenopause pattern.

Dr. Maya Okonkwo
Reviewed by Dr. R. Chen, MD
7 min
Illustration · Eliza Park for HerClarity

The honest truth about “normal” labs in perimenopause

Standard GP panels (CBC, CMP, TSH) can be completely normal in a woman who is in a textbook perimenopause pattern. That’s not a lab failure; it reflects how perimenopause works.

Perimenopause is a clinical diagnosis, based on symptoms and cycle history using the STRAW+10 staging framework. There is no single confirmatory blood test. Major guidelines (NAMS, Endocrine Society, ACOG) agree: in women over 45 with classic symptoms and irregular cycles, additional hormone testing rarely changes management and is usually unnecessary.

What basic bloodwork does do well is rule out conditions that mimic or compound perimenopause—like thyroid disease, iron deficiency, or diabetes—so you don’t miss a treatable problem while attributing everything to “the change.”

---

CBC – and why ferritin matters

A CBC looks at red cells, white cells, and platelets. In perimenopause, its main role is to detect anaemia from heavy or irregular bleeding.

But haemoglobin is a late marker of iron depletion. Ferritin (iron stores) drops first. You can have a normal haemoglobin and very low ferritin, with fatigue, brain fog, palpitations, cold intolerance, and poor exercise tolerance that feel identical to perimenopause.

  • Ask specifically for CBC + ferritin (ferritin is not part of a standard CBC).
  • Many labs still flag ferritin as “normal” down to ~12 µg/L, even though symptoms often improve once ferritin is ≥50 µg/L.

---

CMP – what it catches and what it misses

A CMP checks kidney function, liver function, random glucose, electrolytes, and proteins. In perimenopause workups, it’s mainly for ruling out organ disease and picking up obvious glucose problems.

What it doesn’t include:

  • Lipids – LDL and HDL patterns shift during the menopause transition and affect cardiovascular risk. You need a separate fasting lipid panel.
  • Good screening for insulin resistance – CMP glucose is usually non‑fasting. For midlife screening, ask for fasting glucose and HbA1c. Insulin sensitivity typically declines during perimenopause, and symptoms of insulin dysregulation overlap heavily with perimenopausal symptoms.

---

TSH – and when to go further

TSH is the key screening test because thyroid dysfunction can look almost identical to perimenopause (fatigue, sleep issues, mood changes, hair loss, weight changes, cycle changes).

  • Typical reference range: ~0.4–4.0 mIU/L (lab‑dependent).
  • If TSH is upper‑normal (e.g. >2.5–3.0 mIU/L) and you’re symptomatic, it’s reasonable to add free T4 and anti‑TPO antibodies.
  • Elevated anti‑TPO with high‑normal or high TSH suggests Hashimoto’s thyroiditis, which is common and often under‑diagnosed for years.

A normal TSH does not completely rule out early autoimmune thyroid disease, especially if symptoms are classic for hypothyroidism.

---

What to ask for vs what to skip

Ask for:

  • CBC with ferritin – ferritin must be ordered separately.
  • Fasting glucose and HbA1c – not just random glucose from a CMP.
  • TSH, with a plan to add free T4 and anti‑TPO if TSH is borderline and symptoms fit.
  • Fasting lipid panel – total cholesterol, LDL, HDL, triglycerides.
  • Vitamin B12 – especially if on metformin, PPIs, or a plant‑heavy diet; B12 deficiency can mimic perimenopausal fatigue and cognitive symptoms.

Usually not worth fighting for:

  • A single FSH – wildly variable in perimenopause; one value doesn’t confirm or exclude the diagnosis.
  • Saliva hormone testing – not validated, not guideline‑endorsed, and too variable for clinical decisions.
  • Big private “hormone panels” – estradiol, progesterone, FSH, LH, testosterone, DHEA‑S across a single draw are hard to interpret without precise cycle timing and serial measurements.

---

Bottom line

  • Perimenopause is diagnosed from symptoms + cycle pattern, not from a single lab.
  • Normal CBC, CMP, and TSH do not rule it out.
  • Targeted labs are still crucial to rule out look‑alike conditions and to manage midlife health risks (iron status, thyroid, glucose, lipids, B12).
Sources
  1. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832–1843. doi:10.1056/NEJMra1401038.
  2. El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention. Circulation. 2020;142(25):e506–e532. doi:10.1161/CIR.0000000000000912.
  3. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Endocr Pract. 2012;18(6):988–1028. doi:10.4158/EP12280.GL.
  4. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop +10. J Clin Endocrinol Metab. 2012;97(4):1159–1168. doi:10.1210/jc.2011-3362.
  5. Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975–4011. doi:10.1210/jc.2015-2236.
  6. The 2022 Hormone Therapy Position Statement of the North American Menopause Society. Menopause. 2022;29(7):767–794. doi:10.1097/GME.0000000000002028.
The Friday Briefing

What the research says this week.

One email Friday morning. Plain-English summaries, no fluff.

Free. Unsubscribe anytime.